GIPGLP-1 Tirzepatide

in stock

email: eric@yan-xi.com

whatsapp/wechat: +8613131197877

GIPGLP-1 Tirzepatide

2023788-19-2 - Names and Identifiers

NameTirzepatide

Synonyms GIPGLP-1 Tirzepatide

CAS 2023788-19-2

2023788-19-2 - Physico-chemical Properties

Molecular FormulaC225H348N48O68

Molar Mass4813.45

2023788-19-2 - What is tesiparatide?

Tesiparatide is used in conjunction with diet and exercise to improve glycemic control in adults with type 2 diabetes.

Tesiparatide is not used to treat type 1 diabetes.

Tesiparatide can also be used for other unlisted uses.

Warning

If you have symptoms of a thyroid tumor, such as swelling or lumps in the neck, difficulty swallowing, hoarseness or shortness of breath, call your doctor immediately.

Before taking this medicine

If you are allergic to tirzepatide or have the following conditions, you should not use tirzepatide:

Personal or family history of medullary thyroid cancer (a type of thyroid cancer); or

Multiple endocrine neoplasms type 2 (glandular neoplasms).

tell your doctor if you ever:

Pancreatic problems;

Nephropathy;

Serious stomach problems, such as digestion of food or slowing gastric emptying (gastroparesis); or

Diabetic retinopathy (a diabetic complication affecting the eye).

It is not known whether telepatide can harm unborn babies. Tell your doctor if you are pregnant or planning to be pregnant.

Tesiparatide will reduce the effect of contraceptives. Ask your doctor about other birth control options, such as injections, implants, skin patches, vaginal rings, condoms, diaphragms, cervical caps, or contraceptive sponges. If you take birth control pills, you may need to use different birth control pills within 4 weeks after starting to take ticepatide, and use them for 4 weeks each time you increase the dose.

Ask doctors if it is safe to breastfeed when using this drug.

2023788-19-2 - How should tirzepatide be used?

Follow all instructions on the prescription label and read all drug guidelines or instructions. Your doctor may occasionally change your dose. Use drugs strictly according to instructions.

Tesiparatide was injected under the skin once a week. If you change the date of dosing, allow at least 3 days between dosing.

You can use tesiapatide with or without food.

Your healthcare provider will tell you where to inject tesiapatide. Do not inject the same position twice in a row.

You may have hypoglycemia, feel very hungry, dizzy, agitated, confused, anxious or trembling. For rapid treatment of hypoglycemia, eat or drink fast-acting sugars (juice, hard candy, biscuits, raisins or non-weight loss soda).

You can inject tesiapatide and insulin in the same area (such as the upper arm), but not next to it.

Do not mix insulin and tesiapatide in the same injection.

Don't share this drug with others, even if they have the same symptoms as you.

Stress, illness, surgery, exercise, drinking or skipping meals can affect blood sugar levels. Consult your doctor before you change your dosage or medication schedule.

Each injection pen or prefilled syringe can only be used once. Use it once and throw it away, even if there is still medicine in it. Use a puncture-proof "sharp object" container. Follow state or local laws to find out what to do with this container. Keep it out of reach of children and pets.

Store the tirzepatide in the refrigerator and avoid light. Do not freeze tesiapatide, throw away if the drug has frozen.

You can also store tesiparatide at room temperature for up to 21 days before use.

What should be avoided when using tirzepatide?

Do not share an injection pen or pre-filled syringe with others, even if the needle has been replaced. Sharing these devices allows infection or disease to spread from one person to another.

Side effects of tesiparatide

If you have the following conditions, please stop using tirzepatide and seek emergency medical help:

Signs of allergic reactions: urticaria; dyspnea; feeling dizzy; swelling of face, lips, tongue or throat; or

Pancreatitis-Severe pain in the upper abdomen spreads to the back, nausea and vomiting.

Tesipatide may cause serious side effects. Please call your doctor immediately if the following conditions occur:

Severe stomach problems;

Changes in vision;

Symptoms of thyroid tumor-neck swelling or mass, dysphagia, hoarseness, or shortness of breath;

Gallbladder problems-chalky stool, stomach pain after eating, nausea, heartburn, abdominal distension, and severe upper abdominal pain, which may spread to the back;

Hypoglycemia-headache, hunger, weakness, sweating, confusion, irritability, dizziness, increased heart rate or nervousness; or

Kidney problems-little or no urination, swollen feet or ankles, feeling tired or short of breath.

Common side effects of texiparatide may include:

Nausea, diarrhea, decreased appetite, vomiting; or

Constipation, indigestion or stomach pain.

This is not a complete list of side effects, and other side effects may occur. Call your doctor for medical advice on side effects.

2023788-19-2 - Which drugs affect texiparatide?

Tesipatide can slow down your digestion, and it may take longer for your body to absorb any drugs you take orally.

Tell your doctor about all your other drugs, especially:

Insulin or oral diabetes drugs.

This list is incomplete. Other drugs may affect tesiparatide, including prescription and over-the-counter drugs, vitamins and herbal products. Not all possible drug interactions are listed here.

2023788-19-2 - Reference Information

introductiontirzepatide is a weekly glucose-dependent insulinotropic polypeptide (GIP, also known as: gastric inhibitory polypeptide) receptor . GIP and GLP-1 are hormones secreted by intestinal tract, which can promote insulin secretion. tirzepatide the integration of two insulin-stimulating effects into a single molecule represents a new class of drugs for the treatment of type 2 diabetes.